XDH and chronic kidney disease: Recently, an RCT in patients with stage 3–4 CKD (Controlled Trial of Slowing of Kidney Disease Progression from the Inhibition of Xanthine Oxidase trial: CKD-FIX; follow-up, 104 weeks) failed to confirm the benefits of allopurinol on kidney outcomes29.